19 C
February 21, 2024
The Hona News

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

In patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from anemia—a lack of red blood cells and hemoglobin—which can progress to acute leukemia. Imetelstat, a new agent beyond the current standard of care, may help to avoid blood transfusions, which can be a burden for MDS patients, especially over a long period of time.

Source link

Related posts

How can children, adolescents and adults who are overweight or obese be motivated to participate in health programs?


Drug repairs systems that remove Alzheimer's-causing waste from the brain, study shows


Postpartum depression pill now available to women, drug maker says


Leave a Comment